SYSTEMATIC LITERATURE REVIEW ON MULTI-INDICATION PRICING MODELS IN ONCOLOGICAL DRUGS

被引:2
|
作者
Manganelli, A. [1 ]
Badia, X. [2 ]
Gonzalez, P. [3 ]
机构
[1] CRES UPF, Barcelona, Spain
[2] Omakase Consulting, Barcelona, Spain
[3] Bristol Myers Squibb, Madrid, Spain
关键词
D O I
10.1016/j.jval.2017.08.391
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCN308
引用
收藏
页码:A467 / A467
页数:1
相关论文
共 50 条
  • [31] A review of multi-product pricing models
    Soon, Wanmei
    [J]. APPLIED MATHEMATICS AND COMPUTATION, 2011, 217 (21) : 8149 - 8165
  • [32] A Systematic Literature Review on Pricing Strategies in the Sharing Economy
    Yang, Meijian
    Xia, Enjun
    [J]. SUSTAINABILITY, 2021, 13 (17)
  • [33] Non-steroidal anti-inflammatory drugs in the oncological surgical population: beneficial or harmful? A systematic review of the literature
    Cata, J. P.
    Guerra, C. E.
    Chang, G. J.
    Gottumukkala, V.
    Joshi, G. P.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2017, 119 (04) : 750 - 764
  • [34] Adolescent Idiopathic Scoliosis (AIS) - an indication for surgery? A systematic review of the literature
    Weiss, Hans-Rudolf
    [J]. DISABILITY AND REHABILITATION, 2008, 30 (10) : 799 - 807
  • [35] A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation
    Jayabalan, Nanthini
    Oronsky, Bryan
    Cabrales, Pedro
    Reid, Tony
    Caroen, Scott
    Johnson, Aishwarya M.
    Birch, Natalia A.
    O'Sullivan, John D.
    Gordon, Richard
    [J]. DRUGS, 2023, 83 (05) : 389 - 402
  • [36] A systematic literature review of multicriteria and multi-objective models applied in risk management
    Teixeira de Almeida, Adiel
    Hazin Alencar, Marcelo
    Vitelli Garcez, Thalles
    Jose Pires Ferreira, Rodrigo
    [J]. IMA JOURNAL OF MANAGEMENT MATHEMATICS, 2017, 28 (02) : 153 - 184
  • [37] A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation
    Nanthini Jayabalan
    Bryan Oronsky
    Pedro Cabrales
    Tony Reid
    Scott Caroen
    Aishwarya M. Johnson
    Natalia A. Birch
    John D. O’Sullivan
    Richard Gordon
    [J]. Drugs, 2023, 83 : 389 - 402
  • [38] Enterprise maturity models: a systematic literature review
    Sarmento dos Santos-Neto, Joao Batista
    Cabral Seixas Costa, Ana Paula
    [J]. ENTERPRISE INFORMATION SYSTEMS, 2019, 13 (05) : 719 - 769
  • [39] IS IT POSSIBLE TO ESTIMATE THE WELFARE ECONOMIC LOSS TO SOCIETY OF NOT HAVING VALUE-BASED DIFFERENTIAL PRICING FOR MULTI-INDICATION PHARMACEUTICALS: AN EMPIRICAL ANALYSIS IN DENMARK, NORWAY, AND SWEDEN
    Ehlers, L. H.
    Birch, C. R.
    Ehlers, L. H.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S292 - S292
  • [40] Analysis of variability models: a systematic literature review
    Pol'la, Matias
    Buccella, Agustina
    Cechich, Alejandra
    [J]. SOFTWARE AND SYSTEMS MODELING, 2021, 20 (04): : 1043 - 1077